The present invention relates to methods for the treatment of disorders mediated by MICA-expressing cells using antibodies, antibody fragments, and derivatives thereof that specifically bind MICA. The invention also relates to antibodies； cells producing such antibodies； methods of making such antibodies； fragments, variants, and derivatives of the antibodies； and pharmaceutical compositions comprising the same.
